Skip to main content

Advertisement

Volume 6 Supplement 1

Symposium Mammographicum 2004

Using magnetic resonance to diagnose breast cancer and predict therapeutic response

Introduction

Neoplastic tissue contains elevated levels of choline-containing metabolites (tCho) [1, 2]. The purpose of this study is to determine whether magnetic resonance spectroscopy (MRS) with magnetic resonance imaging (MRI) can be a noninvasive technique for determining whether a breast abnormality is benign or malignant and to monitor response to neoadjuvant chemotherapy (CT).

Materials and methods

Women scheduled for a breast biopsy or scheduled to CT were recruited for our study. All studies were done with a 4 T MRI/MRS scanner. A baseline scan was done prior to the start of CT and 24 hours after CT. Suspicious lesions were identified and measured with a fat-suppressed high-resolution 3D FLASH image (Gd-TPA, 0.1 mmol/kg). Concentrations of tCho were quantified [3]. Each scan was interpreted by evaluation of lesion size, architecture, signal intensity, and tCho.

Results

Twenty-six out of 69 patients had infiltrative ductal carcinoma, 10/69 patients had infiltrative lobular carcinoma, 3/69 patients had ductal carcinoma in situ, 1/69 patients had lobular carcinoma in situ, and 29/69 patients were found to have benign breast lesions. Eight patients have been through CT. Tumor response was seen in six patients. MRS could detect decreased [tCho] within 24 hours after CT. In the six patients with decreased [tCho] at 24 hours, 100% showed diminished tumor size measured by MRI after 9 weeks of CT. However, the two patients with sustained or elevated [tCho] at 24 hours failed to have response to CT.

Conclusion

Based on these results, we expect that the addition of MRS to MRI will provide a noninvasive technique for determining whether a breast abnormality is benign or malignant. Furthermore, the [tCho] measured at 24 hours appears to predict response to CT.

References

  1. 1.

    Mackinnon WB, et al: Radiology. 1997, 204: 661-666.

  2. 2.

    Katz-Brull R, et al: J Natl Cancer Inst. 2002, 94: 1197-1203. 10.1093/jnci/94.16.1197.

  3. 3.

    Bolan PJ, et al: Magn Reson Med. 2003, 50: 1134-1143. 10.1002/mrm.10654.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nelson, M. Using magnetic resonance to diagnose breast cancer and predict therapeutic response. Breast Cancer Res 6, P15 (2004). https://doi.org/10.1186/bcr834

Download citation

Keywords

  • Magnetic Resonance Imaging
  • Ductal Carcinoma
  • Magnetic Resonance Spectroscopy
  • Breast Lesion
  • Diagnose Breast Cancer